Study of Norplant implants in Shanghai: three-year experience
- PMID: 1979289
- DOI: 10.1016/0020-7292(90)90521-l
Study of Norplant implants in Shanghai: three-year experience
Abstract
A clinical follow-up study conducted in Shanghai, China confirmed earlier reports that the Norplant implants, Norplant-1 and Norplant-2, are both highly effective with high continuation rates. The implants, however, tend to cause menstrual disturbance, spotting and bleeding. The mean hemoglobin value, however, did not change and the blood pressure remained stable. The report of 8 cases of thrombocytopenia among 301 Norplant-2 users is a source of concern.
Similar articles
-
Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.Drug Saf. 2003;26(5):303-35. doi: 10.2165/00002018-200326050-00002. Drug Saf. 2003. PMID: 12650633 Review.
-
Norplant contraceptive subdermal implants: one year experience in Singapore.Contraception. 1988 May;37(5):457-69. doi: 10.1016/0010-7824(88)90016-9. Contraception. 1988. PMID: 3136971
-
A two-year study of acceptability, side effects, and effectiveness of Norplant and Norplant-2 implants in the People's Republic of China.Contraception. 1988 Dec;38(6):641-57. doi: 10.1016/0010-7824(88)90047-9. Contraception. 1988. PMID: 3146463
-
A 5-year evaluation of NORPLANT contraceptive implants in China.Obstet Gynecol. 1994 May;83(5 Pt 1):673-8. Obstet Gynecol. 1994. PMID: 8164924 Clinical Trial.
-
Norplant: subdermal implant system for long-term contraception.Am J Obstet Gynecol. 1989 May;160(5 Pt 2):1286-92. doi: 10.1016/s0002-9378(89)80014-6. Am J Obstet Gynecol. 1989. PMID: 2497646 Review.
Cited by
-
Hormonal contraceptives for contraception in overweight or obese women.Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4. Cochrane Database Syst Rev. 2016. PMID: 27537097 Free PMC article. Review.
-
Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.Drug Saf. 2003;26(5):303-35. doi: 10.2165/00002018-200326050-00002. Drug Saf. 2003. PMID: 12650633 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources